Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that w.e.f. 01-May-2025, (i) Mr. Sachin Mehta is resigned as the Chief ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sudarshan Pharma Industries has informed the stock exchange about a change at the Chief Financial Officer position, effective 1st May 2025. Mr. Sachin Mehta has stepped down as CFO but will continue to serve as the Joint Managing Director of the company. In his place, Mr. Manoj Lodha has been appointed as the new CFO. Mr. Lodha is a qualified Chartered Accountant, Cost Accountant, and Law Graduate with over 30 years of experience in finance, taxation, corporate law, and debt structuring. He previously served as President and CFO of Jain Irrigation Systems Limited for 25 years and has worked with rating agencies like S&P, Fitch, and Moody's. The filing also discloses that Mr. Sachin Mehta is a relative of Mr. Hemal Mehta, the Chairman and Managing Director.
This is a senior finance leadership change, but continuity is maintained since the outgoing CFO continues as Joint Managing Director. The new CFO brings strong credentials from a large listed company, which should reassure investors about financial governance.